LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

ICU Medical Inc

Затворен

СекторЗдравеопазване

147.27 -3.8

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

144.56

Максимум

152.49

Ключови измерители

By Trading Economics

Приходи

-39M

-3.4M

Продажби

-12M

537M

Марж на печалбата

-0.632

Служители

15,000

EBITDA

-40M

67M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+15.24% upside

Дивиденти

By Dow Jones

Следващи печалби

19.02.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

716M

3.7B

Предишно отваряне

151.07

Предишно затваряне

147.27

Настроения в новините

By Acuity

34%

66%

87 / 352 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bullish Evidence

ICU Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

11.02.2026 г., 23:47 ч. UTC

Горещи акции

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11.02.2026 г., 22:59 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Grab Holdings to Buy U.S.-Based Stash Financial

11.02.2026 г., 23:54 ч. UTC

Печалби

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11.02.2026 г., 23:50 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

11.02.2026 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11.02.2026 г., 23:49 ч. UTC

Печалби

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11.02.2026 г., 23:45 ч. UTC

Печалби

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11.02.2026 г., 23:42 ч. UTC

Печалби

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11.02.2026 г., 23:41 ч. UTC

Печалби

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11.02.2026 г., 23:40 ч. UTC

Печалби

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11.02.2026 г., 23:35 ч. UTC

Пазарно говорене

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11.02.2026 г., 23:18 ч. UTC

Пазарно говорене

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11.02.2026 г., 23:14 ч. UTC

Пазарно говорене

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11.02.2026 г., 22:59 ч. UTC

Печалби

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11.02.2026 г., 22:59 ч. UTC

Печалби

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11.02.2026 г., 22:59 ч. UTC

Печалби

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11.02.2026 г., 22:58 ч. UTC

Печалби

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11.02.2026 г., 22:57 ч. UTC

Печалби

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11.02.2026 г., 22:54 ч. UTC

Печалби

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11.02.2026 г., 22:53 ч. UTC

Печалби

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11.02.2026 г., 22:47 ч. UTC

Печалби

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11.02.2026 г., 22:47 ч. UTC

Печалби

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11.02.2026 г., 22:23 ч. UTC

Печалби

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11.02.2026 г., 22:22 ч. UTC

Печалби

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11.02.2026 г., 22:22 ч. UTC

Печалби

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11.02.2026 г., 22:19 ч. UTC

Печалби

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11.02.2026 г., 22:18 ч. UTC

Печалби

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11.02.2026 г., 22:18 ч. UTC

Печалби

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11.02.2026 г., 22:18 ч. UTC

Печалби

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11.02.2026 г., 22:16 ч. UTC

Печалби

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Сравнение с други в отрасъла

Ценова промяна

ICU Medical Inc Прогноза

Ценова цел

By TipRanks

15.24% нагоре

12-месечна прогноза

Среден 175 USD  15.24%

Висок 175 USD

Нисък 175 USD

Според 1 анализатори от Wall Street, предложили 12-месечна ценова цел за ICU Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

1 ratings

1

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

137.16 / N/AПодкрепа & съпротива

Краткосрочен план

Very Strong Bullish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Strong Bearish Evidence

Настроение

By Acuity

87 / 352 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat